Tatiana Besse‐Hammer

A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer

Martin Schüler, Ahmad Awada, Philipp Harter et al. · Breast Cancer Research and Treatment · 2012 · 86 citations · Full text

Medicine, Oncology, Pharmacology +16

Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial

Julien Coussement, Nassim Kamar, Marie Matignon et al. · Clinical Microbiology and Infection · 2020 · 74 citations · Full text

Medicine, Nephrology, Urology +15

A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer

Carole Nagant, Fanny Ponthieux, Julie Smet et al. · International Journal of Infectious Diseases · 2020 · 65 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Neurophysiological markers of cue reactivity and inhibition subtend a three-month period of complete alcohol abstinence

Salvatore Campanella, Elisa Schröder, Hendrik Kajosch et al. · Clinical Neurophysiology · 2019 · 40 citations · Full text

Life Sciences, Neuroscience, Psychology +16

First-in-human phase I safety, pharmacokinetic (PK), and pharmacodynamic (PD) analysis of the oral MEK-inhibitor AS703026 (two regimens [R]) in patients (pts) with advanced solid tumors.

J.P. Delord, Nadine Houédé, Ahmad Awada et al. · Journal of Clinical Oncology · 2010 · 36 citations

Medicine, Oncology, Pharmacology +15